A. Cueff

548 total citations
10 papers, 394 citations indexed

About

A. Cueff is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, A. Cueff has authored 10 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in A. Cueff's work include Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). A. Cueff is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). A. Cueff collaborates with scholars based in France. A. Cueff's co-authors include S. Fieffé, A. Dalac, Michel Toubeau, Franck Bonnetain, Mélanie Gauthier, Claire Schvartz, Dimitri Papathanassiou, Tienhan Sandrine Dabakuyo‐Yonli, Éric François and Anne Thirot Bidault and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Annals of Oncology.

In The Last Decade

A. Cueff

10 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Cueff France 6 180 159 141 105 70 10 394
Marco Stella Italy 9 219 1.2× 172 1.1× 162 1.1× 102 1.0× 26 0.4× 19 464
Duc Le Canada 10 153 0.8× 30 0.2× 85 0.6× 97 0.9× 33 0.5× 26 308
Enza Di Felice Italy 7 147 0.8× 97 0.6× 88 0.6× 70 0.7× 49 0.7× 12 284
Per Å. Høisæter Norway 12 64 0.4× 63 0.4× 50 0.4× 289 2.8× 36 0.5× 28 455
Shaolong Sun China 10 132 0.7× 38 0.2× 70 0.5× 56 0.5× 32 0.5× 21 331
Piotr Spychalski Poland 10 127 0.7× 17 0.1× 94 0.7× 106 1.0× 34 0.5× 34 324
Emin Yıldırım Türkiye 9 123 0.7× 66 0.4× 125 0.9× 124 1.2× 13 0.2× 18 436
Hayriye Tatlı Doğan Türkiye 11 107 0.6× 38 0.2× 82 0.6× 81 0.8× 26 0.4× 41 338
H. Al‐Abadi Germany 10 137 0.8× 18 0.1× 147 1.0× 144 1.4× 63 0.9× 24 326
Gordana Pupić Serbia 10 91 0.5× 98 0.6× 108 0.8× 49 0.5× 9 0.1× 32 325

Countries citing papers authored by A. Cueff

Since Specialization
Citations

This map shows the geographic impact of A. Cueff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Cueff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Cueff more than expected).

Fields of papers citing papers by A. Cueff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Cueff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Cueff. The network helps show where A. Cueff may publish in the future.

Co-authorship network of co-authors of A. Cueff

This figure shows the co-authorship network connecting the top 25 collaborators of A. Cueff. A scholar is included among the top collaborators of A. Cueff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Cueff. A. Cueff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gobbo, Jessica, Isabelle Desmoulins, Marine Gilabert, et al.. (2022). OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients. BMC Cancer. 22(1). 41–41. 1 indexed citations
2.
Goirand, Françoise, A. Cueff, Aurélie Bertaut, et al.. (2018). 5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer. Oncotarget. 9(14). 11559–11571. 52 indexed citations
4.
Marilier, Sophie, et al.. (2015). Assessment of the interest of the geriatric oncology consultation among French general practitioners. Journal of Geriatric Oncology. 7(1). 47–52. 2 indexed citations
5.
Créhange, G., Alexandre Cochet, A. Cueff, et al.. (2015). Early radiation response between GnRH agonist versus antagonist combined with radiotherapy in high-risk prostate cancer.. Journal of Clinical Oncology. 33(7_suppl). 97–97. 4 indexed citations
6.
Cochet, Alexandre, A. Cueff, L. Cormier, et al.. (2014). Pattern of occult nodal relapse diagnosed with 18F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy. Radiotherapy and Oncology. 111(1). 120–125. 27 indexed citations
7.
Marthey, Lysiane, António Sá Cunha, Jean‐Frédéric Blanc, et al.. (2014). FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort. Annals of Surgical Oncology. 22(1). 295–301. 127 indexed citations
8.
Marthey, Lysiane, António Sá Cunha, Jean Frédéric Blanc, et al.. (2013). Folfirinox for Locally Advanced Pancreatic Adenocarcinoma. Results of an Ageo Multicenter Prospective Study. Annals of Oncology. 24. iv12–iv12. 5 indexed citations
9.
Créhange, G., A. Cueff, Laurent Mineur, et al.. (2013). Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy. BMC Research Notes. 6(1). 492–492. 7 indexed citations
10.
Schvartz, Claire, Franck Bonnetain, Tienhan Sandrine Dabakuyo‐Yonli, et al.. (2012). Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients. The Journal of Clinical Endocrinology & Metabolism. 97(5). 1526–1535. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026